ATE17647T1 - Verwendung der haloessigsaeuren in homoeopathischen dosen fuer die menschliche und veterinaermedizin und in praeparaten fuer die koerperpflege. - Google Patents

Verwendung der haloessigsaeuren in homoeopathischen dosen fuer die menschliche und veterinaermedizin und in praeparaten fuer die koerperpflege.

Info

Publication number
ATE17647T1
ATE17647T1 AT82400378T AT82400378T ATE17647T1 AT E17647 T1 ATE17647 T1 AT E17647T1 AT 82400378 T AT82400378 T AT 82400378T AT 82400378 T AT82400378 T AT 82400378T AT E17647 T1 ATE17647 T1 AT E17647T1
Authority
AT
Austria
Prior art keywords
preparations
human
veterinary medicine
body care
haloacetic acids
Prior art date
Application number
AT82400378T
Other languages
English (en)
Inventor
Foll Jean Le
Original Assignee
Foll Jean Le
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foll Jean Le filed Critical Foll Jean Le
Application granted granted Critical
Publication of ATE17647T1 publication Critical patent/ATE17647T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16—Halogenated acetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16—Halogenated acetic acids
    • C07C53/18—Halogenated acetic acids containing fluorine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT82400378T 1981-03-05 1982-03-04 Verwendung der haloessigsaeuren in homoeopathischen dosen fuer die menschliche und veterinaermedizin und in praeparaten fuer die koerperpflege. ATE17647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8104434A FR2501043A1 (fr) 1981-03-05 1981-03-05 Application des acides halogenoacetiques a dose homeopathique, en medecine humaine et veterinaire, dans les produits d'hygiene corporelle et dans les produits phytopharmaceutiques
EP82400378A EP0060195B1 (de) 1981-03-05 1982-03-04 Verwendung der Haloessigsäuren in homöopathischen Dosen für die menschliche und Veterinärmedizin und in Präparaten für die Körperpflege

Publications (1)

Publication Number Publication Date
ATE17647T1 true ATE17647T1 (de) 1986-02-15

Family

ID=9255901

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82400378T ATE17647T1 (de) 1981-03-05 1982-03-04 Verwendung der haloessigsaeuren in homoeopathischen dosen fuer die menschliche und veterinaermedizin und in praeparaten fuer die koerperpflege.

Country Status (7)

Country Link
EP (1) EP0060195B1 (de)
JP (1) JPS57176909A (de)
AT (1) ATE17647T1 (de)
CA (1) CA1202193A (de)
DE (1) DE3268737D1 (de)
FR (1) FR2501043A1 (de)
ZA (1) ZA821447B (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1061239A (fr) * 1952-08-05 1954-04-09 Produits destinés à l'hygiène
FR1295338A (fr) * 1959-06-02 1962-06-08 Italseber S P A Nouveaux sels d'ammonium d'acides carboxyliques chlorés et leur préparation
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives
FR2293M (fr) * 1962-07-02 1964-01-27 Jean Meyer Produit poue le traitement des pulpites dentaires.
FR6070M (de) * 1966-12-23 1968-05-27
US4122188A (en) * 1976-12-28 1978-10-24 Vanderbilt University Treatment of hyperlipoproteinemia with a dichloroacetate salt
JPS53136528A (en) * 1977-04-30 1978-11-29 Kanebo Ltd Cosmetics

Also Published As

Publication number Publication date
FR2501043B1 (de) 1984-11-16
FR2501043A1 (fr) 1982-09-10
EP0060195B1 (de) 1986-01-29
DE3268737D1 (en) 1986-03-13
EP0060195A1 (de) 1982-09-15
CA1202193A (en) 1986-03-25
ZA821447B (en) 1983-01-26
JPS57176909A (en) 1982-10-30

Similar Documents

Publication Publication Date Title
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
IT8019118A0 (it) Apparecchio manuale per la cura o il trattamento dei denti.
DK20488A (da) Farmaceutiske praeparater med forlaenget afgivelse
IL78553A (en) Therapeutic compositions of phosphonylmethoxyalkyl adenines
NO1994018I1 (no) Mometasonfuroat
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE56022T1 (de) Insulinabkoemmlinge und arzneimittel die diese enthalten.
ES2088959T3 (es) 11-beta-aril-4-estreno, procedimiento para su preparacion y aplicacion como medicamento.
ES533050A0 (es) Procedimiento para preparar agentes cosmeticos para el cuidado de la salud y del cuerpo
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
AT363601B (de) Mittel zur pflege und behandlung der haut
ATE17647T1 (de) Verwendung der haloessigsaeuren in homoeopathischen dosen fuer die menschliche und veterinaermedizin und in praeparaten fuer die koerperpflege.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE428438T1 (de) Tcf-ii enthaltende medizinische zusammensetzung
JPS5583758A (en) Novel 3*44diazaabicyclo*4*1*0*heptenee*2**onee *5**its manufacture and medicine containing it
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
FR2336945A1 (fr) Composition pour la sterilisation des femmes et des femelles d'animaux
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
NO158675C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater.
DE3064854D1 (en) Quail-egg lyophilisate for the treatment of immuno-allergic diseases
ATE163264T1 (de) Verwendung von n,n'-bis 3-(ethylamino)propyl-1,7- heptandiamin und einem zytotoxischen mittel
IT7945204A0 (it) Composizione farmaceutica per la terapia delle sterilita' maschile
RO76345A3 (ro) Medicament complex utilizabil in tratamentul sechelelor radioterapieisi cheloidelor chirurgicale
DE68901018D1 (de) Arzneimittel zur regulierung der hormonellen sekretionen und zur behandlung der weiblichen sterilitaet.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties